Is the hormonal regulation of the lower esophageal sphincter function known ?
M. Mignon, G. Cadiot, E. Malikova (Paris)
The answer to this question must be no : indeed, although many peptides have demonstrated a pharmacological effect on the lower esophageal sphincter (LES), none of them has been found to exert a definite physiological control on the sphincteric function [1]. It must be remembered, however, that to be classified as physiological, any hormonal action must satisfy the following requirements :
a) a significant correlation must exist between any modification of LES pressure and any variation in serum hormone concentration during physiological stimulation (e.g. meal).
b) continuous perfusion of the putative hormone to a level equivalent to physiological concentration in the serum must reproduce the physiological action of the hormone on LES function.
However, these perequisites do not take into account, either the possible paracrine
or neurocrine interaction of peptides, or the role, yet unexplored, of the intermediate products of peptides metabolism. The study of the effects of the administration of specific antibodies directed against hormones may in the future bring new insight in the hormonal aspect of LES function regulation.
It seems currently accepted that the resting tone of LES is secondary to both myogenous and neurogenous mechanisms. It is also accepted that LES relaxation, whether it is spontaneous or evoked by swallowing or esophageal distension, is mediated essentially by neurogenous phenomena. According to this theoretical schematisation, peptides can only exert a modulating effect, acting either at the muscular level itself or at the neurotransmission mechanism (interfering for instance with the non-adrenergic non-cholinergic inhibitory neurons). The effects of various peptides and neuro-transmitters on LES function are summarized in Table 1.
Table 1. Effects of various peptides and neurotransmitters on LES pressure in man
Increase in pressure |
Decrease in pressure |
||
Gastrin |
Cholecystokinin |
||
Motilin |
Secretin |
||
Substance P |
Glucagon |
||
Bombesin |
VIP, PHI |
||
Galanin |
Gastric Inhibitory Peptide |
||
Pancreatic polypeptide |
Somatostatin |
||
|
Calcitonin-gene related peptide |
||
|
TRH |
||
|
Opioids |
||
In the human, the lower esophagus contains numerous nervous fibers containing VIP, substance P, enkephalins and the neuropeptide PYY. These peptides are potential neuro-transmitters [2, 3]. Several arguments support strongly a physiological role for VIP [4] and substance P [5, 6] in LES pressure regulation.
In addition, motilin could as well be responsible for LES contractions noted during interdigestive phases II and III of the migrating motor complex [7].
References